ArchiMed picks up Deallus

The all-equity deal saw Deallus's senior management also investing.

This acquisition marks ArchiMed's fourth since closing its debut fund on its €150m hard-cap in June 2015. Previous deals include the €12m purchase of Medistream, a minority stake in Primo and the acquisition of RehabWorks.

Company
Deallus is a life-sciences-focused consultant, providing advice on product introduction and processes for maintaining corporate innovation. It works with pharmaceutical, biotech and vaccine businesses.

Deallus was founded in 2004 and is headquartered in London with further offices in New York, Los Angeles, Princeton, Tokyo and Singapore. The company employs 80 consultants and generates turnover of £15m.

People
Robin Filmer-Wilson is a managing partner at ArchiMed. Claudio D'Ambrosio is CEO of Deallus.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Buyouts
• Support services
• United Kingdom